#narcolepsy

2 briefings

FDA Turns Down Tris Pharma's Narcolepsy Drug as Agenus Scraps Cancer Trial

Jul 13, 2026, 7:11 PM

Takeda Doubles Down on Orexin Drug Data as Competition Heats Up

Jun 15, 2026, 8:18 PM